4//SEC Filing
Kewalramani Reshma 4
Accession 0000875320-24-000225
CIK 0000875320other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:08 PM ET
Size
4.7 KB
Accession
0000875320-24-000225
Insider Transaction Report
Form 4
Kewalramani Reshma
DirectorCEO & President
Transactions
- Sale
Common Stock
2024-11-08$515.00/sh−15,198$7,826,970→ 75,772 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1, which was entered into on 02/07/2024.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001735944
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:08 PM ET
- Size
- 4.7 KB